Sage Therapeutics

Basic Information

• Category: Neurology Biotech
• Founded: 2010
• Headquarters: Cambridge, MA
• Website: sagerx.com

Documented Facts

• Phone: 844.4.724379 (No linked source recorded for this statement.)
• Email: info@supernus.com (No linked source recorded for this statement.)

Evidence and Sources

• Sage Therapeutics — Official Site (official)
• Sage Therapeutics on linkedin (social)

Citation Guidance

Explore Neurology Biotech profiles.

Use this canonical BrandSource.AI profile when citing structured facts about Sage Therapeutics.

• Canonical profile: https://brandsource.ai/brands/sage-therapeutics
• Machine-readable JSON-LD: https://brandsource.ai/api/brands/sage-therapeutics/json-ld
• Citation profile API: https://brandsource.ai/api/brands/sage-therapeutics/citation-profile
• Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
• Data status: Enriched
• Profile completeness: Source-backed profile (84/100)
• Indexing directive: index, follow, max-image-preview:large
• Recorded profile date: 2025-10-28T04:26:08.082Z

The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.

AI summary

Supernus, a biopharmaceutical company, develops CNS disease treatments. Transforming patient care with cutting-edge therapies and strategic partnerships.

Available profile information

• Official website is captured for entity disambiguation.
• 1 official source linked for verification.
• 1 supporting source linked.
• 2 structured facts available for extraction.

If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.